Table 2.
Differences between infrequent and frequent developers over twelve years
| Total developers n = 96 | Difference | ||
| Infrequent developers n = 55 % (95% CI) |
Frequent developers n = 41 % (95% CI) |
% | |
| Scientific literature reviewed | 94.1 (89.0–99.2) | 97.3 (96.4–98.2) | 3.2 |
| Computerized literature search | 76.6 (66.9–86.3) | 91.6 (90.1–93.2) | 15.0 |
| Search strategy stated in guideline | 37.1 (25.5–48.8) | 37.3 (34.6–40.1) | 0.2 |
| Quality of evidence graded | 38.1 (27.5–48.7) | 51.6 (48.8–54.4) | 13.5 |
| Passive dissemination strategies | 90.6 (84.3–96.9) | 91.4 (89.8–92.9) | 0.8 |
| Educational strategies | 45.8 (35.1–56.7) | 48.3 (45.5–51.1) | 2.5 |
| Active implementation strategies | 29.4 (19.5–39.3) | 33.0 (30.4–35.6) | 3.6 |
| Effectiveness of dissemination/implementation strategies formally evaluated | 3.7 (0–7.8) | 9.2 (7.6–10.8) | 5.5 |
| Plan to evaluate dissemination/implementation in future | 29 (17.4–40.7) | 44.4 (41.2–47.6) | 15.4 |
| Formally evaluated impact on health outcomes | 6.1 (0.8–11.4) | 14.1 (12.1–16) | 8.0 |
| Plan to evaluate impact on health outcomes in future | 32.3 (20.3–44.2) | 43.9 (40.7–47.1) | 11.6 |
| Companion consumer version | 12.9 (5.7–20.2) | 25.4 (23–27.8) | 12.5 |
| Plan to produce consumer version in future | 7.1 (1.5–12.6) | 20.5 (18.3–22.7) | 13.4 |